WO2014171184A1 - 医療用管状体 - Google Patents
医療用管状体 Download PDFInfo
- Publication number
- WO2014171184A1 WO2014171184A1 PCT/JP2014/054563 JP2014054563W WO2014171184A1 WO 2014171184 A1 WO2014171184 A1 WO 2014171184A1 JP 2014054563 W JP2014054563 W JP 2014054563W WO 2014171184 A1 WO2014171184 A1 WO 2014171184A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tubular body
- marker
- medical
- diameter
- medical tubular
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/844—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents folded prior to deployment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/825—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0082—Three-dimensional shapes parallelepipedal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
- A61F2250/0063—Nested prosthetic parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
Definitions
- the present invention relates to a medical tubular body that can be expanded in diameter, and is used, for example, to treat a lesion where a blood vessel or other in-vivo lumen is narrowed or occluded. More specifically, the present invention relates to a medical tubular body typified by a stent placed in a lesioned part of a living body lumen, or a medical tubular body used for removing a thrombus generated in a lesioned part.
- a medical tubular body typified by a stent is generally a medical instrument for treating various diseases caused by stenosis or occlusion of a blood vessel or other living body lumen.
- the medical tubular body includes a lesion that is expanded from the inside, such as a stenosis or occlusion, and is placed in the lesion to maintain the inner diameter of the lumen, or a thrombus that has developed in or around the lesion. Examples include those that are removed from the entangled body and restored to the luminal inner diameter at the lesion.
- the medical tubular body is used in the body, but once the medical tubular body is inserted into the body, its position cannot be visually confirmed. Therefore, usually, a marker including a radiopaque material is provided at a predetermined position of the medical tubular body, and the treatment is performed while confirming the exact position of the marker under fluoroscopy.
- the marker visibility is required to be improved in terms of accurate delivery to the lesion (delivery) and alignment of the exact expanded range (ie, working range) in the expanded state.
- FIG. 14 of Patent Document 1 describes an intravascular medical instrument (medical tubular body) that can be inserted into a small-diameter delivery system by making the marker shape longer in the axial direction and shorter in the radial direction. ing.
- Patent Document 2 describes a medical tubular body in which markers having a predetermined distance are arranged around the end of the tubular body for the purpose of facilitating the determination of the direction of the medical tubular body. Yes.
- the present invention has excellent visibility under fluoroscopy, insertion into a catheter, and slidability within a catheter, and can suppress contact between a marker and a tubular body or adjacent markers in a reduced diameter state.
- An object of the present invention is to provide a medical tubular body that can be reduced in diameter.
- the present inventor has conducted detailed studies on various shapes and the like of the marker in order to solve the above problems.
- the present inventor considered that the space left inside the tubular body could not be used when the diameter of the medical tubular body was reduced, and completed the present invention by arranging a marker in this internal space. It came.
- the medical tubular body of the present invention that has solved the above-described problems has a tubular body that can be expanded in diameter and a marker formed inside the tubular body. Since the marker of the medical tubular body of the present invention is formed inside the expandable tubular body, when the diameter of the tubular body contracts, the space inside the tubular body is effectively utilized and the marker is in the space. It will fit in. Therefore, even if the markers do not contact each other or the marker and the tubular body, or even if they contact each other, the degree of contact is reduced as compared with the conventional case. As a result, the diameter of the tubular body when contracted can be made smaller than before.
- the marker is fixed to the inner surface of the tubular body. This is because the outer shape of the medical tubular body cannot be made sufficiently small if the marker is formed other than the inner side surface such as the outer side surface of the tubular body.
- the marker is formed on a non-deformable portion constituting a part of the tubular body.
- the marker may be detached from the tubular body along with the deformation of the tubular body.
- the marker is formed on a flat portion on the inner surface of the tubular body.
- the inner surface of the tubular body is a flat surface, it is easy to increase the contact area between the inner surface of the tubular body and the marker, so that the tubular body and the marker can be more firmly fixed.
- the marker is preferably welded to the inner surface of the tubular body. It is possible to provide a medical tubular body with reduced risk of marker dropping.
- the marker is sized to be accommodated in an inner space when the tubular body is reduced in diameter. If the size of the marker can be accommodated in the inner space when the diameter of the tubular body is reduced, the marker and the tubular body do not come into contact with each other, so that the outer shape of the medical tubular body can be made sufficiently small.
- the medical tubular body has at least two markers, and the markers have such a size that the markers do not contact each other when the tubular body is reduced in diameter. If the markers do not contact each other, the outer shape of the medical tubular body can be made sufficiently small.
- the two markers are formed at different positions in the axial direction of the tubular body. Even if one marker is placed inside the tubular body, if there are two markers in the same space inside the tubular body, the markers may contact each other depending on the size of the marker. . Therefore, by forming the two markers at different positions in the axial direction of the tubular body, contact between the markers can be avoided, and the outer shape of the medical tubular body can be made sufficiently small.
- the tubular body preferably includes a plurality of struts having different lengths, and the marker is formed at the end of each strut. If the struts having different lengths are used, it becomes easy to form markers at different positions in the axial direction of the tubular body.
- an embodiment in which a gap is formed between one end of the marker and the tubular body can be preferably implemented. Since the tubular body does not necessarily have a reduced diameter as designed, it may be advantageous to reduce the diameter of the tubular body by leaving some gaps.
- the marker may have a longer axial length than the radial length of the tubular body.
- the marker is arranged using the inner space of the tubular body. However, since the inner space of the tubular body is naturally limited, it is formed long in the axial direction of the tubular body. Thus, the marker volume can be increased.
- the medical tubular body is a self-expanding type. Since the medical tubular body of the present invention has a shape in which the marker protrudes toward the inside of the tubular body, a self-expanding medical tubular body is preferably used rather than a balloon-type medical tubular body. .
- the tubular body preferably has a network structure, and the network structure is preferably configured by a combination of cells that are continuous in a spiral direction.
- the marker is preferably columnar.
- the medical tubular body of the present invention has a tubular body that can be expanded and a marker formed inside the tubular body, the markers or the marker and the tubular body are in contact with each other. Even if there is no contact or contact, the degree of contact is reduced compared to the conventional case. As a result, the diameter of the tubular body when contracted can be made smaller than before.
- FIG. 1 is a development view of the medical tubular body according to the first embodiment of the present invention.
- FIG. 2 is an enlarged view of an end of the medical tubular body according to the first embodiment of the present invention.
- Fig.3 (a) is the figure which looked at the medical tubular body (at the time of diameter expansion) concerning Embodiment 1 from the axial direction
- FIG.3 (b) is the medical tubular body concerning Embodiment 1 ( It is the figure which looked at the time of diameter reduction from the axial direction.
- FIG. 4 is a development view of the medical tubular body according to the second embodiment of the present invention.
- FIG.5 (a) is the figure which looked at the medical tubular body (at the time of diameter expansion) concerning Embodiment 2 from the axial direction
- FIG.5 (b) is the medical tubular body concerning Embodiment 2 ( It is the figure which looked at the time of diameter reduction from the axial direction
- FIG. 6 is a development view of the medical tubular body according to the third embodiment of the present invention
- Fig.7 (a) is the figure which looked at the medical tubular body (at the time of diameter expansion) concerning Embodiment 3 from the axial direction
- FIG.7 (b) is the medical tubular body concerning Embodiment 3 ( It is the figure which looked at the time of diameter reduction from the axial direction.
- FIG.7 (a) is the figure which looked at the medical tubular body (at the time of diameter expansion) concerning Embodiment 3 from the axial direction
- FIG.7 (b) is the medical tubular body concerning Embodiment 3 ( It is the figure which looked at the time of diameter reduction from the axial direction.
- FIG. 8 is a development view of the medical tubular body according to the fourth embodiment of the present invention.
- FIG. 9A is an end perspective view of the medical tubular body according to the fourth embodiment (when the diameter is expanded), and FIG. 9B is a medical tubular body according to the fourth embodiment (the diameter is expanded). It is the figure which looked at time from the axial direction.
- FIG. 10A is an end perspective view of the medical tubular body according to the fourth embodiment (when the diameter is reduced), and FIG. 10B is a medical tubular body according to the fourth embodiment (the diameter is reduced). It is the figure which looked at time from the axial direction.
- FIG. 11 is a development view of the medical tubular body according to the fifth embodiment of the present invention.
- FIG. 12A is an end perspective view of the medical tubular body according to the fifth embodiment (when the diameter is expanded), and FIG. 12B is a medical tubular body according to the fifth embodiment (the diameter is expanded). It is the figure which looked at time from the axial direction.
- FIG. 13A is an end perspective view of the medical tubular body according to the fifth embodiment (when the diameter is reduced), and FIG. 13B is a medical tubular body according to the fifth embodiment (the diameter is reduced). It is the figure which looked at time from the axial direction.
- the medical tubular body of the present invention has a tubular body that can be expanded in diameter and a marker formed inside the tubular body. Since the marker of the medical tubular body of the present invention is formed inside the expandable tubular body (that is, inward in the radial direction of the tubular body), the marker is tubular even when the diameter of the tubular body is contracted. It fits in the void inside the body. Therefore, even if the markers do not contact each other or the marker and the tubular body, or even if they contact each other, the degree of contact is reduced as compared with the conventional case. In the present specification, a configuration in which a marker is removed from a medical tubular body is referred to as a “tubular body”.
- the medical tubular body is used in a living body lumen. For example, it is placed in a lesioned part of a living body lumen to maintain or expand the diameter of the living body lumen.
- a peripheral protection device such as a peripheral protection filter, a thrombectomy device for removing a thrombus formed in a lumen in a living body, and the like.
- the medical tubular body is used by being attached to a catheter (delivery system: delivery device) or the like having a portion where the medical tubular body is placed for delivery (delivery) to a lesioned part.
- the medical tubular body is (i) a balloon that mounts (mounts) a medical tubular body on the outer surface of the balloon and transports it to the lesioned area, and expands the medical tubular body with the balloon at the lesioned area. It can be classified into an expandable type and (ii) a self-expandable type that expands itself by removing the member that suppresses expansion at the lesioned part by transporting to the lesioned part with a catheter having a member that suppresses expansion.
- the medical tubular body is reduced in a direction perpendicular to the longitudinal axis of the tubular body (that is, the radial direction of the tubular body) in a state where the medical tubular body is installed in a delivery system composed of a balloon, a catheter, or the like, and the longitudinal axis direction.
- the diameter is reduced to a cylindrical shape that is longer than the expanded state.
- the diameter of the reduced diameter state can be reduced as compared with the balloon expansion type.
- Tubular body A tubular body is a structure which can be expanded in diameter, for example comprised by mesh structures, such as a mesh.
- being able to expand the diameter means that the tube can be expanded in a direction perpendicular to the major axis (radial direction) of the tubular body, and can be contracted (reduced diameter) from the expanded state.
- the tubular body is formed, for example, from a pattern of interconnected structural elements that expand and contract in the circumferential and axial directions.
- the tubular body in the present invention can be applied in any pattern and is therefore not limited to any particular stent shape or structural element pattern.
- a marker including a radiopaque material is provided at a predetermined position of the medical tubular body so that the medical tubular body can be observed under X-ray fluoroscopy.
- the marker does not need to completely block X-rays, and may have an X-ray transmittance that can detect the presence of the marker under fluoroscopy.
- FIG. 1 is a development view of the medical tubular body according to the first embodiment of the present invention.
- the medical tubular body 100 has a distal end 101 and a proximal end 102, and has a metal mesh portion 111 between the distal end 101 and the proximal end 102.
- the metal mesh portion 111 is configured by a combination of continuous cells 112.
- the metal mesh portion 111 is bent into a tubular shape with the longitudinal direction as the central axis, and the two long sides of the metal mesh portion 111 are joined to form a tubular body. For this, FIG. 9A and FIG. 12A are helpful.
- the medical tubular body 100 includes, for example, a marker housing at the distal end 101 or the proximal end 102 and markers 121 to 124 fixed to the marker housing.
- the marker housing will be described below using an enlarged view of the vicinity of the marker 121 of the medical tubular body 100.
- FIG. 2 is an enlarged view of the vicinity of the marker 121 of the medical tubular body 100 according to the first embodiment of the present invention.
- a marker 121 is fixed to the inner side surface of the marker housing 131 formed at the distal end 101 (that is, the inner side surface of the tubular body).
- the material used for the metal mesh portion 111 is not particularly limited as long as it is a material that can withstand a strong load at the time of deformation or indwelling, such as expansion or contraction, but is stainless steel for medical use.
- 316L stainless steel, tantalum, Co—Cr (cobalt chromium) alloy, Ni—Ti (nickel-titanium) alloy and the like can be preferably used.
- a nickel-titanium alloy can be preferably used because it has shape memory characteristics and elastic characteristics and is excellent in workability.
- an alloy containing about 50% by mass to about 60% by mass of nickel can be preferably used.
- the metal mesh portion 111 may include a biodegradable material such as a biodegradable polymer or metal.
- the biodegradable material may be a composite of at least two biodegradable polymers and / or metals.
- the tubular body is cut into the pattern of the cells 112 to produce a tubular body, and then the shape is memorized in a state where the tubular body is expanded, and the marker 121 and the like are attached from the inside of the tubular body.
- a laser processing method an electric discharge processing method, a mechanical cutting method, an etching method, or the like
- the tubular body is cut into the pattern of the cells 112 to produce a tubular body, and then the shape is memorized in a state where the tubular body is expanded, and the marker 121 and the like are attached from the inside of the tubular body.
- the material of the marker housing 131 is preferably the same material as that of the metal mesh part 111 in terms of strength and corrosion resistance, and is formed integrally with the metal mesh part 111.
- the marker housing 131 has an inner surface in the radial direction for attaching the marker 121.
- the marker housing 131 only needs to have a shape and a size as a base to which the marker 121 is attached. Since the marker housing 131 desirably has a stable shape as a mounting base for the marker 121, it is desirable that the marker housing 131 be a non-deformable (non-movable) portion that is not deformed by the expansion and contraction of the tubular body.
- FIG. 3A is a view of the distal end 101 of the medical tubular body 100 (when the diameter is expanded) according to the first embodiment viewed from the axial direction
- FIG. It is the figure which looked at the distal end 101 of this medical tubular body (at the time of diameter reduction) from the axial direction.
- the markers 121 to 124 are formed inside the tubular body constituting the medical tubular body 100, so that the diameter of the medical tubular body 100 is reduced.
- the void inside the tubular body is effectively used and the marker is contained in the void.
- the degree of contact is reduced as compared with the conventional case.
- the diameter of the tubular body when contracted can be made smaller than before.
- the size of the marker housings 131 to 134 is desirably in a range that does not inhibit the diameter reduction of the medical tubular body 100 by not contacting each other when the diameter of the medical tubular body 100 is reduced.
- the cross-sectional shape in the direction perpendicular to the longitudinal axis of the medical tubular body 100 can be, for example, circular, oval, elliptical, square, rectangular, or rhombic.
- the material constituting the marker 121 is not particularly limited as long as it is a material having higher radiopacity than the constituent material of the medical tubular body 100.
- a metal material is preferable from the viewpoint of workability such as an influence on a living body, or a workability such as being difficult to deform when attached to the marker housing 131.
- platinum, palladium, and tantalum are preferable because they have excellent biological compatibility with the human body.
- tantalum is preferred because it has a small difference in electrochemical potential and is difficult to corrode.
- the method for attaching the markers 121 to 124 to the marker housings 131 to 134 is not particularly limited as long as the method does not drop off during the transportation of the medical tubular body 100 or the indwelling operation in the lesioned part.
- the method for example, welding, brazing, caulking, and the like can be mentioned. This is because, in the case of welding, a material (such as brazing) different from the marker housing or the marker material is not used. On the other hand, in the case of brazing, a material different from the marker housing or the marker material is used, and in the case of caulking, it is difficult to obtain the smoothness of the outer surface in the radial direction of the marker housing.
- the inner surface 141 of the marker housing shown in FIG. 2 is flat, and a straight line length corresponding to the diameter of the welding spot is required. Preferably there is.
- the diameter of the welding spot is preferably 80% or less of the short side of the fixed surface of the marker, more preferably 70% or less, and still more preferably 60%, from the viewpoint of not adversely affecting the fluoroscopic image.
- the diameter of the welding spot is preferably 20% or more of the short side of the fixed surface of the marker, more preferably 30% or more, and even more preferably 40% or more.
- the diameter of the welding spot is preferably about 40 ⁇ m to 100 ⁇ m, more preferably about 50 ⁇ m to 90 ⁇ m.
- the size of the tubular body is not particularly limited, but in Embodiment 1, the outer diameter of the tubular body is, for example, about 0.36 to 0.46 mm when the diameter is reduced, and is about 4.0 to 4.5 mm when the diameter is expanded, for example. .
- the length of the marker in the axial direction is, for example, 1.0 to 5.0 mm, and the length of the marker in the radial direction of the tubular body is, for example, about 0.20 to 0.35 mm.
- FIG. 4 is a development view of the medical tubular body according to the second embodiment of the present invention.
- the medical tubular body 100 has a distal end 101 and a proximal end 102, and has a metal mesh portion 111 between the distal end 101 and the proximal end 102.
- the medical tubular body 100 according to the second embodiment of the present invention basically has the same configuration as that of the medical tubular body 100 according to the first embodiment of the present invention. The same reference numerals are given and description thereof is omitted.
- the medical tubular body 100 according to the second embodiment of the present invention is different from the medical tubular body 100 according to the first embodiment in that, in the first embodiment, the markers 121 to 124 are at the same position in the axial direction of the tubular body.
- the markers 121 to 124 are at the same position in the axial direction of the tubular body.
- at least two markers 121 and 122 are formed at different positions in the axial direction of the tubular body.
- FIG. 5A is a view of the distal end 101 of the medical tubular body 100 (in the case of diameter expansion) according to the second embodiment when viewed from the axial direction
- FIG. It is the figure which looked at the distal end 101 of this medical tubular body (at the time of diameter reduction) from the axial direction.
- the effect similar to that of the medical tubular body 100 according to the first embodiment that is, the markers 121 and 122 are formed inside the tubular body. Even when the diameter of the tubular body is reduced, the void inside the tubular body is effectively utilized so that the marker is accommodated in the gap, and the diameter of the tubular body when the diameter is reduced can be made smaller than before.
- the markers 121 and 122 are in the axial direction of the tubular body. Therefore, when the diameter of the tubular body is reduced, the marker 121 and the marker 122 do not interfere with each other and are accommodated in the internal space of the tubular body.
- forming each marker at a different position in the axial direction of the tubular body can reduce the diameter of the medical tubular body 100 when the diameter is reduced. It can be seen that this is an effective technique for reducing the size.
- FIG. 6 is a development view of the medical tubular body according to the third embodiment of the present invention.
- the medical tubular body 100 has a distal end 101 and a proximal end 102, and has a metal mesh portion 111 between the distal end 101 and the proximal end 102.
- the medical tubular body 100 according to the third embodiment of the present invention basically has the same configuration as that of the medical tubular body 100 according to the second embodiment of the present invention. The same reference numerals are given and description thereof is omitted.
- the medical tubular body 100 according to the third embodiment of the present invention is different from the medical tubular body 100 according to the second embodiment in that the lengths of the column 151 and the column 152 are different from each other in the second embodiment.
- the lengths of the support columns 153 are the same, and the lengths of the support columns 152 and 154 are also the same. However, in the third embodiment, the support columns 151 to 154 have different lengths.
- FIG. 7A is a view of the distal end 101 of the medical tubular body 100 (when the diameter is expanded) according to the third embodiment viewed from the axial direction, and FIG. It is the figure which looked at the distal end 101 of this medical tubular body (at the time of diameter reduction) from the axial direction.
- FIG. 7B since the markers 121 to 124 are formed at different positions in the axial direction of the tubular body, the markers 121 to 124 do not interfere with each other when the diameter of the tubular body is reduced. It is stored in the internal void of the body.
- each marker when the medical tubular body 100 has two or more markers, forming each marker at a different position in the axial direction of the tubular body can reduce the diameter of the medical tubular body 100 when the diameter is reduced. It can be seen that this is an effective technique for reducing the size.
- This embodiment is advantageous in that the positions of the markers 121 to 124 can be easily changed by simply changing the design of the length of the column.
- FIG. 8 is a development view of the medical tubular body according to the fourth embodiment of the present invention.
- the medical tubular body 100 has a distal end 101 and a proximal end 102, and has a metal mesh portion 111 between the distal end 101 and the proximal end 102.
- the metal mesh portion 111 is configured by a combination of cells 112 that are continuous in the spiral direction.
- the medical tubular body 100 according to the fourth embodiment of the present invention basically has the same configuration as the medical tubular body 100 according to the third embodiment of the present invention. The same reference numerals are given and description thereof is omitted.
- the medical tubular body 100 according to the fourth embodiment of the present invention is different from the medical tubular body 100 according to the third embodiment in that the length of the support columns 151 to 154 is different in the third embodiment.
- the positions of the markers 121 to 124 in the body axial direction are different, in the fourth embodiment, as shown in FIG. 8, the cells 112 are made continuous in the spiral direction to form the metal mesh portion 111.
- the positions of the markers 121 to 124 in the axial direction of the tubular body are different.
- FIG. 9A is a perspective view of the vicinity of the distal end 101 of the medical tubular body according to the fourth embodiment (when expanded in diameter), and FIG. 9B shows the distal end 101 viewed from the axial direction.
- FIG. 10A is a perspective view of the vicinity of the distal end 101 of the medical tubular body according to the fourth embodiment (when the diameter is reduced), and FIG. 10B is a view of the distal end 101 seen from the axial direction. It is a figure.
- the markers 121 to 124 are formed at different positions in the axial direction of the tubular body, the markers 121 to 124 interfere with each other when the diameter of the tubular body is reduced. It fits in the internal space of the tubular body.
- forming each marker at a different position in the axial direction of the tubular body can reduce the diameter of the medical tubular body 100 when the diameter is reduced. It can be seen that this is an effective technique for reducing the size.
- the strut may be deformed in the in vivo lumen when the strut is formed to be very long.
- the tubular body is formed by the configuration of the metal mesh portion 111 itself. This is advantageous in that the rigidity of the end of the tubular body can be maintained without using a long support column.
- the markers 121 to 124 are arranged in a straight line with a certain angle with respect to the axial direction of the medical tubular body 100.
- FIG. 8 is a development view, but the markers 121 to 124 can be seen in a straight line even when the metal mesh portion 111 is bent to form a tubular shape and the medical tubular body 100 is observed from the side. This is because the end of the tubular body has a shape obtained by obliquely cutting the cylinder (that is, a shape like the tip of an injection needle). As the diameter of the tubular body shrinks, the angle between the straight line in which the markers 121 to 124 are arranged and the axial direction of the tubular body becomes smaller.
- the straight line in which the markers 121 to 124 are aligned becomes parallel to the axis of the tubular body.
- the expansion / contraction of the tubular body in the expanded state, the semi-expanded state, the contracted state, or the like is determined from the angle formed by the straight line in which the markers 121 to 124 are arranged and the axis of the tubular body. You can know the degree.
- the markers 121 to 124 have some gaps on the side opposite to the side fixed to the marker housings 131 to 134, and the diameter is reduced. It may not be perfectly aligned with the axial direction of the tubular body. Of course, it is ideal that the markers 121 to 124 are perfectly aligned in that a large-capacity marker can be placed by making maximum use of the voids in the tubular body, but the tubular body is not necessarily reduced in diameter as designed. Since this is not always the case, leaving some clearance may be advantageous for reducing the diameter of the tubular body. Therefore, it is also a preferable aspect to employ a configuration in which the markers 121 to 124 are not arranged in a straight line when the diameter of the tubular body is reduced.
- FIG. 11 is a development view of the medical tubular body according to the fifth embodiment of the present invention.
- FIG. 12A is a perspective view of the vicinity of the distal end 101 of the medical tubular body according to the fifth embodiment (when expanded), and FIG. 12B shows the distal end 101 viewed from the axial direction.
- FIG. 13A is a perspective view of the vicinity of the distal end 101 of the medical tubular body according to the fifth embodiment (when the diameter is reduced), and FIG. 13B shows the distal end 101 viewed from the axial direction. It is a figure.
- the medical tubular body 100 according to the fifth embodiment of the present invention has substantially the same configuration as the medical tubular body 100 according to the fourth embodiment of the present invention.
- 124 is formed in a columnar shape, but the fifth embodiment is different in that the markers 121 to 124 are formed in a prismatic shape. If the markers 121 to 124 are prismatic shapes, the contact surface with the marker housings 131 to 134 is large, which is advantageous in terms of fixing strength.
- the medical tubular body typified by a stent contracts in the radial direction in a cross section perpendicular to the longitudinal axis of the medical tubular body, extends in the longitudinal axis direction, and expands from the expanded state. It has an elongated cylindrical shape. Due to the structure of the catheter, the self-expandable medical tubular body must have a smaller outer diameter in a reduced diameter state as compared with the balloon expandable type. Therefore, the medical tubular body of the present invention that can reduce the outer diameter in a reduced diameter state can be more preferably used in a self-expanding type.
- the medical tubular body of the present invention can be suitably used for various medical tubular bodies such as drug-coated stents and biodegradable stents in addition to those exemplified.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
本発明は、X線透視下での視認性、カテーテル内への挿入性、カテーテル内での摺動性に優れ、縮径状態でマーカーと管状体または隣接するマーカーどうしの接触を抑制でき、一層小さく縮径することのできる医療用管状体を提供することを目的とする。
医療用管状体は、生体内管腔内で用いられるものであり、例えば生体内管腔の病変部に留置して生体内管腔の径を維持ないし拡張するためのステントや、生体内管腔に形成された血栓を除去するための血栓回収デバイス、あるいは末梢保護フィルターなどの末梢保護デバイス等が挙げられる。
医療用管状体には、例えば、(i)1本の線状の金属もしくは高分子材料からなるコイル状のタイプ、(ii)金属チューブをレーザーなどで切り抜き加工したタイプ、(iii)線状の部位を溶接し組み立てたタイプ、(iv)複数の線状金属を織って作ったタイプ等がある。
管状体は、例えばメッシュなどの網目構造で構成されている拡径可能な構造体である。本発明において拡径可能とは、管状体の長軸に垂直な方向(径方向)に伸張することができ、径が伸張された状態からは逆に収縮(縮径)することもできることを意味する。管状体は、例えば周方向および軸方向に伸縮する、相互に連結している構造要素のパターンから形成される。本発明において管状体は、任意のパターンに適用可能であり、したがって、いかなる特定のステントの形状あるいは構造要素のパターンにも限定されない。
医療用管状体をひとたび体内に入れると、その位置を目視で確認することはできない。そのため、X線透視下において医療用管状体を観察できるよう、X線不透過材料を含むマーカーが医療用管状体の所定位置に設けられる。マーカーは、X線を完全に遮断するものでなくてもよく、X線透視下においてマーカーの存在が検知できる程度のX線透過率を有していればよい。
以下、本発明の実施の形態1にかかる医療用管状体について、図面を用いて説明する。図1は、本発明の実施の形態1にかかる医療用管状体の展開図である。医療用管状体100は、遠位端101、近位端102を有し、遠位端101と近位端102の間には金属メッシュ部111を有している。金属メッシュ部111は、連続したセル112の組み合わせにより構成されている。金属メッシュ部111は、長手方向を中心軸として管状に曲げられ、金属メッシュ部111の2つの長辺どうしが接合されることにより管状体として構成される。これについては、図9(a)、図12(a)が参考となる。
以下、本発明の実施の形態2にかかる医療用管状体について、図面を用いて説明する。図4は、本発明の実施の形態2にかかる医療用管状体の展開図である。医療用管状体100は、遠位端101、近位端102を有し、遠位端101と近位端102の間には金属メッシュ部111を有している。本発明の実施の形態2にかかる医療用管状体100は、基本的には、本発明の実施の形態1にかかる医療用管状体100と同様の構成を有しているため、同じ構成には同じ符号を付してその説明を省略する。
以下、本発明の実施の形態3にかかる医療用管状体について、図面を用いて説明する。図6は、本発明の実施の形態3にかかる医療用管状体の展開図である。医療用管状体100は、遠位端101、近位端102を有し、遠位端101と近位端102の間には金属メッシュ部111を有している。本発明の実施の形態3にかかる医療用管状体100は、基本的には、本発明の実施の形態2にかかる医療用管状体100と同様の構成を有しているため、同じ構成には同じ符号を付してその説明を省略する。
以下、本発明の実施の形態4にかかる医療用管状体について、図面を用いて説明する。図8は、本発明の実施の形態4にかかる医療用管状体の展開図である。医療用管状体100は、遠位端101、近位端102を有し、遠位端101と近位端102の間には金属メッシュ部111を有している。金属メッシュ部111は、螺旋方向に連続したセル112の組み合わせにより構成されている。本発明の実施の形態4にかかる医療用管状体100は、基本的には、本発明の実施の形態3にかかる医療用管状体100と同様の構成を有しているため、同じ構成には同じ符号を付してその説明を省略する。
以下、本発明の実施の形態5にかかる医療用管状体について、図面を用いて説明する。図11は、本発明の実施の形態5にかかる医療用管状体の展開図である。図12(a)は、実施の形態5にかかる医療用管状体(拡径時)の遠位端101付近の斜視図であり、(b)は、その遠位端101を軸方向から見た図である。また図13(a)は、実施の形態5にかかる医療用管状体(縮径時)の遠位端101付近の斜視図であり、(b)は、その遠位端101を軸方向から見た図である。
101 遠位端
102 近位端
111 金属メッシュ部
112 セル
121,122,123,124 マーカー
131,132,133,134 マーカーハウジング
141 マーカーハウジングの内側面
151,152,153,154 支柱
Claims (14)
- 拡径可能な管状体と、前記管状体の内側に形成されたマーカーとを有することを特徴とする医療用管状体。
- 前記マーカーは、前記管状体の内側面に固定されている請求項1に記載の医療用管状体。
- 前記マーカーは、前記管状体の一部を構成する非変形部に形成されている請求項1または2に記載の医療用管状体。
- 前記マーカーは、前記管状体の内側面の平面部に形成されている請求項1~3のいずれかに記載の医療用管状体。
- 前記マーカーは、前記管状体の内側面に溶接されている請求項1~4のいずれかに記載の医療用管状体。
- 前記マーカーは、前記管状体の縮径時の内側空隙に収容される大きさである請求項1~5のいずれかに記載の医療用管状体。
- 前記マーカーを少なくとも2つ有しており、前記マーカーは、前記管状体の縮径時に前記マーカーどうしが互いに接触しない大きさを有している請求項1~6のいずれかに記載の医療用管状体。
- 前記2つのマーカーが、前記管状体の軸方向の異なる位置に形成されている請求項7に記載の医療用管状体。
- 前記管状体は長さの異なる複数の支柱を含んでおり、各支柱の端部に前記マーカーが形成されている請求項8に記載の医療用管状体。
- 前記管状体の縮径時において、前記マーカーの一方端は前記管状体との間に空隙を形成している請求項7~9のいずれかに記載の医療用管状体。
- 前記マーカーは、前記管状体の径方向の長さよりも、前記管状体の軸方向の長さのほうが長い請求項1~10のいずれかに記載の医療用管状体。
- 自己拡張型である請求項1~11のいずれかに記載の医療用管状体。
- 前記管状体は網目構造を有しており、該網目構造は、螺旋方向に連続したセルの組み合わせにより構成されている請求項1~12のいずれかに記載の医療用管状体。
- 前記マーカーは、柱状である請求項1~13のいずれかに記載の医療用管状体。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015512338A JP6689605B2 (ja) | 2013-04-16 | 2014-02-25 | 医療用管状体 |
US14/782,133 US10182928B2 (en) | 2013-04-16 | 2014-02-25 | Medical tubular body |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013086133 | 2013-04-16 | ||
JP2013-086133 | 2013-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014171184A1 true WO2014171184A1 (ja) | 2014-10-23 |
Family
ID=51731145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2014/054563 WO2014171184A1 (ja) | 2013-04-16 | 2014-02-25 | 医療用管状体 |
Country Status (3)
Country | Link |
---|---|
US (1) | US10182928B2 (ja) |
JP (2) | JP6689605B2 (ja) |
WO (1) | WO2014171184A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878162B2 (en) | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
US7780721B2 (en) | 2004-09-01 | 2010-08-24 | C. R. Bard, Inc. | Stent and method for manufacturing the stent |
EP1983931B1 (en) * | 2006-02-14 | 2017-01-04 | Angiomed GmbH & Co. Medizintechnik KG | Highly flexible stent and method of manufacture |
WO2017023635A1 (en) | 2015-08-06 | 2017-02-09 | Xiang Zhang | A system for 3d object modeling and tracking in x-ray imaging |
US11241321B2 (en) * | 2016-10-04 | 2022-02-08 | Yasuhiro Shobayashi | Flexible stent |
EP3616656A1 (de) * | 2018-08-29 | 2020-03-04 | Biotronik Ag | Röntgenmarker für eine gefässstütze |
CN113498334B (zh) * | 2019-01-16 | 2024-05-24 | 爱德华兹生命科学公司 | 用于监测瓣膜扩张的设备和方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002272855A (ja) * | 2001-03-14 | 2002-09-24 | Piolax Medical Device:Kk | ステント |
US20040254627A1 (en) * | 2003-04-04 | 2004-12-16 | Thompson Paul J. | Stent with end adapted for flaring |
JP2008511423A (ja) * | 2004-09-01 | 2008-04-17 | アンギオメット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コムパニー メディツィンテヒニク コマンデイトゲゼルシャフト | ステント及びステント製造方法 |
US20090306760A1 (en) * | 2008-06-06 | 2009-12-10 | Bay Street Medical | Prosthesis and delivery system |
WO2011093941A2 (en) * | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and systems for treating heart failure |
WO2011122444A1 (ja) * | 2010-03-30 | 2011-10-06 | テルモ株式会社 | ステントデリバリーシステム |
WO2012031748A2 (de) * | 2010-09-08 | 2012-03-15 | Phenox Gmbh | Implantat zur beeinflussung des blutflusses bei arteriovenösen fehlbildungen |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US8790391B2 (en) | 1997-04-18 | 2014-07-29 | Cordis Corporation | Methods and devices for delivering therapeutic agents to target vessels |
US20070087028A1 (en) | 1998-04-16 | 2007-04-19 | Robert Falotico | Intraluminal devices for the prevention and treatment of vascular disease |
US20010029351A1 (en) | 1998-04-16 | 2001-10-11 | Robert Falotico | Drug combinations and delivery devices for the prevention and treatment of vascular disease |
US8029561B1 (en) | 2000-05-12 | 2011-10-04 | Cordis Corporation | Drug combination useful for prevention of restenosis |
US6468301B1 (en) | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Repositionable and recapturable vascular stent/graft |
US6788202B2 (en) | 2001-05-07 | 2004-09-07 | Lp Innovations, Inc. | Customer conversion system |
US20040243097A1 (en) | 2000-05-12 | 2004-12-02 | Robert Falotico | Antiproliferative drug and delivery device |
US20020007213A1 (en) | 2000-05-19 | 2002-01-17 | Robert Falotico | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US20020005206A1 (en) | 2000-05-19 | 2002-01-17 | Robert Falotico | Antiproliferative drug and delivery device |
US20020007214A1 (en) | 2000-05-19 | 2002-01-17 | Robert Falotico | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US20020007215A1 (en) | 2000-05-19 | 2002-01-17 | Robert Falotico | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US7419678B2 (en) | 2000-05-12 | 2008-09-02 | Cordis Corporation | Coated medical devices for the prevention and treatment of vascular disease |
US8236048B2 (en) | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
US20050002986A1 (en) | 2000-05-12 | 2005-01-06 | Robert Falotico | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US7300662B2 (en) | 2000-05-12 | 2007-11-27 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US20020051730A1 (en) | 2000-09-29 | 2002-05-02 | Stanko Bodnar | Coated medical devices and sterilization thereof |
MXPA03002870A (es) | 2000-09-29 | 2004-12-06 | Johnson & Johnson | Revestimientos para dispositivos medicos. |
US6746773B2 (en) | 2000-09-29 | 2004-06-08 | Ethicon, Inc. | Coatings for medical devices |
US6863685B2 (en) | 2001-03-29 | 2005-03-08 | Cordis Corporation | Radiopacity intraluminal medical device |
US7261735B2 (en) | 2001-05-07 | 2007-08-28 | Cordis Corporation | Local drug delivery devices and methods for maintaining the drug coatings thereon |
US20020111590A1 (en) | 2000-09-29 | 2002-08-15 | Davila Luis A. | Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
US20070276475A1 (en) | 2000-09-29 | 2007-11-29 | Llanos Gerard H | Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon |
ATE343969T1 (de) | 2000-09-29 | 2006-11-15 | Cordis Corp | Beschichtete medizinische geräte |
US20060222756A1 (en) | 2000-09-29 | 2006-10-05 | Cordis Corporation | Medical devices, drug coatings and methods of maintaining the drug coatings thereon |
US8182527B2 (en) | 2001-05-07 | 2012-05-22 | Cordis Corporation | Heparin barrier coating for controlled drug release |
US8197535B2 (en) | 2001-06-19 | 2012-06-12 | Cordis Corporation | Low profile improved radiopacity intraluminal medical device |
US7195640B2 (en) | 2001-09-25 | 2007-03-27 | Cordis Corporation | Coated medical devices for the treatment of vulnerable plaque |
US7108701B2 (en) | 2001-09-28 | 2006-09-19 | Ethicon, Inc. | Drug releasing anastomosis devices and methods for treating anastomotic sites |
US20030065345A1 (en) | 2001-09-28 | 2003-04-03 | Kevin Weadock | Anastomosis devices and methods for treating anastomotic sites |
US20030065377A1 (en) | 2001-09-28 | 2003-04-03 | Davila Luis A. | Coated medical devices |
US20030204168A1 (en) | 2002-04-30 | 2003-10-30 | Gjalt Bosma | Coated vascular devices |
US7780721B2 (en) | 2004-09-01 | 2010-08-24 | C. R. Bard, Inc. | Stent and method for manufacturing the stent |
US8460372B2 (en) | 2006-11-07 | 2013-06-11 | Dc Devices, Inc. | Prosthesis for reducing intra-cardiac pressure having an embolic filter |
US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
JP2010508093A (ja) | 2006-11-07 | 2010-03-18 | セラマジャー,デイヴィッド,スティーヴン | 心不全を治療するための装置及び方法 |
US8882697B2 (en) | 2006-11-07 | 2014-11-11 | Dc Devices, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
US20110257723A1 (en) | 2006-11-07 | 2011-10-20 | Dc Devices, Inc. | Devices and methods for coronary sinus pressure relief |
US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
US9757107B2 (en) | 2009-09-04 | 2017-09-12 | Corvia Medical, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
US8951223B2 (en) | 2011-12-22 | 2015-02-10 | Dc Devices, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
-
2014
- 2014-02-25 WO PCT/JP2014/054563 patent/WO2014171184A1/ja active Application Filing
- 2014-02-25 US US14/782,133 patent/US10182928B2/en active Active
- 2014-02-25 JP JP2015512338A patent/JP6689605B2/ja active Active
-
2018
- 2018-09-05 JP JP2018166401A patent/JP6736627B2/ja active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002272855A (ja) * | 2001-03-14 | 2002-09-24 | Piolax Medical Device:Kk | ステント |
US20040254627A1 (en) * | 2003-04-04 | 2004-12-16 | Thompson Paul J. | Stent with end adapted for flaring |
JP2008511423A (ja) * | 2004-09-01 | 2008-04-17 | アンギオメット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コムパニー メディツィンテヒニク コマンデイトゲゼルシャフト | ステント及びステント製造方法 |
US20090306760A1 (en) * | 2008-06-06 | 2009-12-10 | Bay Street Medical | Prosthesis and delivery system |
WO2011093941A2 (en) * | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and systems for treating heart failure |
WO2011122444A1 (ja) * | 2010-03-30 | 2011-10-06 | テルモ株式会社 | ステントデリバリーシステム |
WO2012031748A2 (de) * | 2010-09-08 | 2012-03-15 | Phenox Gmbh | Implantat zur beeinflussung des blutflusses bei arteriovenösen fehlbildungen |
Also Published As
Publication number | Publication date |
---|---|
US10182928B2 (en) | 2019-01-22 |
JP6689605B2 (ja) | 2020-04-28 |
US20160058590A1 (en) | 2016-03-03 |
JP2018187477A (ja) | 2018-11-29 |
JPWO2014171184A1 (ja) | 2017-02-16 |
JP6736627B2 (ja) | 2020-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6736627B2 (ja) | 医療用管状体 | |
EP2939640B1 (en) | Highly flexible stent | |
US8778010B2 (en) | Endoluminal prosthesis | |
ES2447790T3 (es) | Endoprótesis | |
EP2227191A1 (en) | Stent with improved mechanical properties | |
JP2009131397A (ja) | 生体器官拡張器具 | |
WO2016130647A1 (en) | Expandable tip medical devices and methods | |
WO2014171183A1 (ja) | 医療用管状体 | |
ES2874058T3 (es) | Stent flexible | |
WO2016167002A1 (ja) | 医療用管状体 | |
KR102558760B1 (ko) | 스텐트 | |
EP3981367A1 (en) | Stent with deflecting connector | |
EP3821857B1 (en) | Stent and method for inspection thereof | |
JP6155765B2 (ja) | 消化管ステント | |
JP5401148B2 (ja) | 生体内留置用ステントおよび生体器官拡張器具 | |
EP3821856B1 (en) | Stent | |
WO2021192636A1 (ja) | 生体内留置用ステントおよびステントデリバリーシステム | |
RU2393820C2 (ru) | Внутрипросветный протез | |
JP2013176485A (ja) | ステント | |
WO2014058043A1 (ja) | 生体内留置部材、ステント、塞栓部材、血管拡張キット及び動脈瘤塞栓キット | |
WO2014162903A1 (ja) | ガルバニック腐食ステント |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14785159 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2015512338 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14782133 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14785159 Country of ref document: EP Kind code of ref document: A1 |